Holly Springs’ Avior Bio launches clinical trial of chronic itch therapy
Its lead product — AV104 — is based on Avior’s patent-pending delivery technology called Speedit Transmucosal Film to treat severe pruritus.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
